13F Pro13F Pro

SEC Form 4 reporting owner

Chimovits Erez

Chimovits Erez has filed 11 Form 4 transactions reported between June 9, 2026 and September 28, 2026, as Director of ADARx Pharmaceuticals, Inc., Director of Braveheart Bio, Inc. and a reporting owner of Upstream Bio, Inc..

Name as filed: Chimovits Erez

Follow Chimovits Erez and get an alert on every new Form 4

Chimovits Erez holds 102.2M shares of ADRX, worth $1.45B, 91.92% of the company.

As of their Sep 28, 2026 Form 4 (filed Sep 30, 2026) · the filing on SEC EDGAR · valued at the Nov 19, 2026 close of $14.16 · 111.2M shares outstanding on Nov 6, 2026 · adjusted for stock splits since

Chimovits Erez holds 3.0M shares of BRVE, worth $57.9M, 3.35% of the company.

As of their Aug 7, 2026 Form 4 (filed Aug 11, 2026) · the filing on SEC EDGAR · valued at the Nov 19, 2026 close of $19.27 · 89.9M shares outstanding on Nov 6, 2026 · adjusted for stock splits since

Open-market buys, 24 mo
$1.0M
1 lines
Open-market sales, 24 mo
None
reported
Companies
3
with Form 4 filings
Latest transaction
Sep 28, 2026
transaction date

Roles and reported holdings

  • ADRXADARx Pharmaceuticals, Inc.
    Sep 28, 2026

    Director

    See footnotes102,212,275 sh

    As of Sep 28, 2026 · Form 4

    24 months: $1.0M bought

  • BRVEBraveheart Bio, Inc.
    Aug 5, 2026 – Aug 7, 2026

    Director

    See footnotes3,006,663 sh

    Also reports 30,000 Stock Option (Right to Buy), not counted as shares.

    As of Aug 7, 2026 · Form 4

    2 lines are priced far from BRVE’s market price that day, so the filing may concern a different security. Left out of totals and holdings; see the filings.

  • UPBUpstream Bio, Inc.
    Jun 9, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

How their buys did since

1 open-market purchase against today’s price: +816.2% on average.

DatePaidReturn
Sep 28, 2026ADRX$1.55split-adj.+816.2%now $14.16

Each purchase at the price on its Form 4, against the latest trade or close, adjusted for stock splits. Past returns say nothing about future ones.

Transaction history

All 11 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 28, 2026ADRXDirectorOpen-market purchaseCode P · indirectAlso reported by GORDON CARL L, ORBIMED ADVISORS LLC61,516$1.0M@ $17.00Form 4
Sep 28, 2026ADRXDirectorConversion of derivativeCode C · indirect256,448—Form 4
Sep 28, 2026ADRXDirectorConversion of derivativeCode C · indirect513,067—Form 4
Sep 28, 2026ADRXDirectorConversion of derivativeCode C · indirect1,333,975—Form 4
Sep 28, 2026ADRXDirectorConversion of derivativeCode C · indirect7,127,019—Form 4
Aug 7, 2026BRVEDirectorConversion of derivativeCode C · indirect40,000,000—Form 4
Aug 7, 2026BRVEDirectorOpen-market purchaseCode P · indirectPrice far from market; may be another securityAlso reported by ORBIMED ADVISORS LLC273,333$4.9M@ $18.00Form 4
Aug 7, 2026BRVEDirectorOpen-market purchaseCode P · indirectPrice far from market; may be another securityAlso reported by ORBIMED ADVISORS LLC1,666,667$30.0M@ $18.00Form 4
Aug 7, 2026BRVEDirectorConversion of derivativeCode C · indirect9,132,420—Form 4
Aug 5, 2026BRVEDirectorGrant or awardCode A · direct30,000—Form 4
Jun 9, 2026UPBGrant or awardCode A · direct17,096—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares each ownership line is left at by the person’s latest Form 4, 4/A or 5: held directly, and through each trust or entity named on the filing. A second class of common stock that converts into the listed one counts as shares; options and restricted stock units are listed but not counted. Value uses the latest trade or close, and the share of the company uses the latest shares-outstanding count the company reported. Where a filing has not yet been read line by line, the figure comes from the latest direct and indirect lines that traded and is shown as “at least”.

2 open-market lines are priced outside 0.67×–1.5× of the stock’s closing price that day. A gap that large usually means the filing reports a different security than the company it is filed under, so those lines are shown but left out of totals and holdings.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.